life-sciences

PubMed MCP server for searching biomedical literature and research articles

BioRender MCP server for creating and accessing scientific illustrations

Scholar Gateway MCP server by Wiley for accessing academic research and publications

Access to bioRxiv and medRxiv preprint data. The bioRxiv Connector gives Claude access to bioRxiv and medRxiv preprint servers, hosting research papers in biological and medical sciences posted before peer review.

Access ClinicalTrials.gov data. The Clinical Trials Connector gives Claude access to ClinicalTrials.gov, the NIH/NLM registry of FDA-regulated clinical studies conducted worldwide.

Access to the ChEMBL Database. The ChEMBL Connector gives Claude access to the ChEMBL Database, a manually curated resource of bioactive drug-like compounds with quantitative binding and functional data against biological targets.

Interact with AI agents built for biology. Owkin build AI agents for biology to accelerate drug discovery and de-risk clinical trials. The Owkin connector currently powers HistoPLUS, an agent that transforms H&E slides from the TCGA database into granular, queryable insights. Researchers can use it to quantify distinct cell types, analyze complex spatial tumor microenvironments, and validate hypotheses through cohort-level survival analysis.

Drug target discovery and prioritisation platform. The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets, integrating publicly available datasets to build and score target-disease associations.

Synapse.org MCP server by Sage Bionetworks for collaborative research data management

Medidata's MCP provides tools for Platform Help and Predictive Site Ranking. Platform Help allows users to query Medidata's platform documentation for answers about products like Rave EDC, Data Connect, and Clinical Data Studio. Predictive Site Ranking enables Intelligent Trials customers to predict which clinical trial sites align with enrollment goals during protocol planning, ranking sites based on indication, past performance, and various study criteria.